Efficacy and safety of cysteamine-isobionicamide complex in postinflammatory hyperpigmentation: A 16-week, randomized, double-blinded, vehicle-controlled trial
Background: Postinflammatory hyperpigmentation (PIH) is a prevalent acquired hyperpigmentation disorder with significant psychosocial implications. Cysteamine has demonstrated notable efficacy and safety in treating hyperpigmentation disorders. This study conducted a double-blinded, randomized clini...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Dermatologica Sinica |
Subjects: | |
Online Access: | http://www.dermsinica.org/article.asp?issn=1027-8117;year=2023;volume=41;issue=4;spage=222;epage=230;aulast=Liu |